Covestor’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6K Sell
394
-9
-2% -$169 ﹤0.01% 1826
2026
Q2
$6K Buy
403
+18
+5% +$314 ﹤0.01% 1852
2026
Q1
$7K Sell
385
-311
-45% -$6.76K ﹤0.01% 1694
2025
Q4
$15K Hold
696
– – 0.01% 1407
2025
Q3
$8K Buy
696
+406
+140% +$5.5K ﹤0.01% 1775
2025
Q2
$5K Sell
290
-1
-0.3% -$20 ﹤0.01% 1759
2025
Q1
$6K Buy
291
+1
+0.3% +$29 ﹤0.01% 1719
2024
Q4
$10K Buy
290
+1
+0.3% +$34 0.01% 1566
2024
Q3
$12K Hold
289
– – 0.01% 1462
2024
Q2
$12K Sell
289
-2
-0.7% -$83 0.01% 1435
2024
Q1
$10K Hold
291
– – 0.01% 1618
2023
Q4
$9K Buy
291
+2
+0.7% +$41 0.01% 1660
2023
Q3
$6K Buy
289
+89
+45% +$2.44K ﹤0.01% 1698
2023
Q2
$5K Sell
200
-1
-0.5% -$32 ﹤0.01% 1712
2023
Q1
$8K Buy
201
+96
+91% +$3.98K 0.01% 1438
2022
Q4
$5K Hold
105
– – ﹤0.01% 1593
2022
Q3
$5K Sell
105
-848
-89% -$46.5K ﹤0.01% 1512
2022
Q2
$56K Buy
953
+2
+0.2% +$164 0.04% 703
2022
Q1
$111K Sell
951
-307
-24% -$35.8K 0.07% 440
2021
Q4
$189K Buy
+1,258
New +$170K 0.26% 34

Other funds holding TNDM

Covestor's TNDM Position: Q3 2026 in Review

Covestor reduced its Tandem Diabetes Care (TNDM) stake by 2.2% in Q3 2026, selling an estimated $169 and leaving 394 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Covestor first reported a position in TNDM in Q4 2021 and has held it in 20 quarters since. The position peaked at $189K in Q4 2021. 111 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Covestor held 394 shares of Tandem Diabetes Care worth $6K as of Q3 2026.
  • Covestor sold 9 Tandem Diabetes Care shares in Q3 2026, an estimated $169.
  • Tandem Diabetes Care made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1826 holding.
  • Covestor first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Tandem Diabetes Care position peaked at $189K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.